Measuring FGF21 Levels in Blood of People With Breast Cancer
Measures the FGF21 protein in blood of people with breast cancer.
Key facts
- Who runs it
- Assiut University
- Where
- Asyut, EgyptSee the site
- Trial code
- Registry title
- Role of FGF21 in Breast Cancer
- Status
- Not yet recruiting
- People taking part
- 84 people, planned
- Started
- Sept 2025
- Expected to end
- Dec 2026
- Type of study
- Observational
- Treatments tested
- ELISA
- Record updated
- 8 August 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for women with breast cancer who are admitted at the south Egypt cancer institute. It measures the blood level of FGF-21.
- Sex
- Women only
- Disease stage
- Breast cancer confirmed by clinical, radiological and pathological tests.
Main reasons for not taking part
- Patients diagnosed with other cancers at the same time.
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- -
Who cannot take part
- -
Where in Egypt
- Assuit university (South Egypt Cancer Institute)Asyut, EgyptContact: Asmaa Asmaa Mostafa Ali, Resident doctorNo longer taking part
About the trial
What the trial wants to find out
The present study aims to evaluate the serum level of FGF-21 in patients with breast cancer and its correlation with clinical, laboratory, and pathological data.
The group in the trial
- Breast cancer patients
Female patients admitted at south Egypt cancer institute who diagnosed as breast cancer based on full clinical, radiological and pathological data.
Treatment: ELISA
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Role of Fibroblast Growth Factor 21(FGF21) in Breast Cancer
- Plain-language title
- Measuring FGF21 Levels in Blood of People With Breast CancerGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 8 August 2025